These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 3027138)

  • 1. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte chemotaxis in generalized pustular psoriasis.
    Zelickson BD; Pittelkow MR; Muller SA; Johnson CM
    Acta Derm Venereol; 1987; 67(4):326-30. PubMed ID: 2445152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin.
    Ternowitz T
    J Am Acad Dermatol; 1987 Jun; 16(6):1169-75. PubMed ID: 3597858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP.
    Ternowitz T; Herlin T; Fogh K
    Acta Pathol Microbiol Immunol Scand C; 1987 Apr; 95(2):47-54. PubMed ID: 3037849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.
    Fräki JE; Jakoi L; Davies AO; Lefkowitz RJ; Snyderman R; Lazarus GS
    J Invest Dermatol; 1983 Sep; 81(3):254-7. PubMed ID: 6309987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monocyte and neutrophil chemotaxis in vitro employing 51Cr-labelled leukocytes.
    Ternowitz T
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct; 93(5):189-93. PubMed ID: 4083015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of leukotriene B4 in the scale extracts of psoriasis and inflammatory pustular dermatoses. Correlation with leukocyte chemotactic activity and C5a anaphylatoxin.
    Takematsu H; Terui T; Tagami H
    Acta Derm Venereol; 1986; 66(1):6-10. PubMed ID: 2424218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of neutrophil chemotactic function in septic patients.
    Tavares-Murta BM; Zaparoli M; Ferreira RB; Silva-Vergara ML; Oliveira CH; Murta EF; Ferreira SH; Cunha FQ
    Crit Care Med; 2002 May; 30(5):1056-61. PubMed ID: 12006803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil and monocyte chemotaxis in pustulosis palmo-plantaris and pustular psoriasis.
    Ternowitz T; Thestrup-Pedersen K
    Br J Dermatol; 1985 Nov; 113(5):507-13. PubMed ID: 4063189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil and monocyte chemotaxis in methotrexate-treated psoriasis patients.
    Ternowitz T; Herlin T
    Acta Derm Venereol Suppl (Stockh); 1985; 120():23-6. PubMed ID: 3869414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil leukocyte migration in psoriasis vulgaris.
    Breathnach SM; Carrington P; Black MM
    J Invest Dermatol; 1981 Apr; 76(4):271-4. PubMed ID: 7205028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased extracellular release of granule enzymes from in vitro-stimulated polymorphonuclear leukocytes in guttate psoriasis.
    Glinski W; Tigalonowa M; Jablonska S; Janczura E
    Inflammation; 1986 Jun; 10(2):99-108. PubMed ID: 3710563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses.
    Czarnetzki B
    Clin Exp Immunol; 1983 Nov; 54(2):486-92. PubMed ID: 6317241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of alpha 5 beta 1 integrins reverses the inhibitory effect of tenascin on chemotaxis of human monocytes and polymorphonuclear leukocytes through three-dimensional gels of extracellular matrix proteins.
    Loike JD; Cao L; Budhu S; Hoffman S; Silverstein SC
    J Immunol; 2001 Jun; 166(12):7534-42. PubMed ID: 11390508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.
    Lawrence RH; Sorrelli TC
    Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear leucocyte chemotaxis in response to leukotriene B4 in treated and untreated psoriatics.
    Green CM; Ferguson J; MacLeod TM; Millar BW; Raffle EJ
    Dermatologica; 1989; 178(1):20-2. PubMed ID: 2537239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.